PLUS THERAPEUTICS, INC. - Director's Dealing 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-01-20

Reporting Person: HOLMES E CARMACK (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-01-20	Common Stock	M	10000	$3.47	Acquired	12472	Direct
2010-01-20	Common Stock	M	10000	$3.12	Acquired	22472	Direct
2010-01-20	Common Stock	S	3900	$9.00	Disposed	18572	Direct
2010-01-20	Common Stock	S	1000	$9.01	Disposed	17572	Direct
2010-01-20	Common Stock	S	800	$9.04	Disposed	16772	Direct
2010-01-20	Common Stock	S	3400	$9.05	Disposed	13372	Direct
2010-01-20	Common Stock	S	2200	$9.06	Disposed	11172	Direct
2010-01-20	Common Stock	S	2300	$9.07	Disposed	8872	Direct
2010-01-20	Common Stock	S	100	$9.075	Disposed	8772	Direct
2010-01-20	Common Stock	S	1300	$9.08	Disposed	7472	Direct
2010-01-20	Common Stock	S	500	$9.09	Disposed	6972	Direct
2010-01-20	Common Stock	S	400	$9.10	Disposed	6572	Direct
2010-01-20	Common Stock	S	800	$9.12	Disposed	5772	Direct
2010-01-20	Common Stock	S	1300	$9.13	Disposed	4472	Direct
2010-01-20	Common Stock	S	1500	$9.14	Disposed	2972	Direct
2010-01-20	Common Stock	S	500	$9.16	Disposed	2472	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-01-20	Non-Qualified Stock Option (Right to Buy)	$3.47	M	10000	Disposed	2013-08-11	Common Stock (20000)	Direct
2010-01-20	Non-Qualified Stock Option	$3.12	M	10000	Disposed	2015-02-02	Common Stock (35000)	Direct

Security	Shares	Ownership
Common Stock	15161	Indirect

F1: The exercise of stock options and sales of shares were executed pursuant to a Rule 10b5-1 Trading Plan.

F2: These shares are held of record by E. Carmack Holmes & Carolyn K Holmes TTEE, Holmes Living Trust DD 05/15/92.

F3: The option vests 1/48th each month after a one-year cliff from date of grant.

F4: The options vest as to 1/48th each month from date of grant.